# Cognition Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cognition-therapeutics

- Industry: Biotechnology
- Headquarters: Purchase, US
- Website: www.cogrx.com
- Total disclosed funding: $16M
- Latest round: Series B (Sep 8, 2015)
- Investors on record: 15

## About

Based in Pennsylvania, US, and founded in 2007 and led by Chief Executive Officer Lisa Ricciardi, Cognition Therapeutics, Inc. operates as a developer of drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. In September 2022, Cognition Therapeutics, Inc. received USD 2.14 million in Grant funding from National Institute on Aging.

Cognition Therapeutics, Inc. specializes in the development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. The company’s product CT1812, which is a an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex. It focuses on neurodegenerative and neuro-ophthalmic diseases that are caused by the age-related buildup of pathogenic proteins such as amyloid beta (Aß) and alpha-synuclein as well as other stressors such as reactive oxygen species (ROS).

## Funding rounds

- Series B, Sep 8, 2015, $12M — Bios Partners, Tech Coast Angels, Golden Seeds, Pittsburgh Life Sciences Greenhouse, M5Invest Partners, Maine Angels, Cowtown Angels, Dolby Family Ventures, ACE Fund, Scale Investors, Ariel Southeast Angel Partners, Ogden CAP, LLC
- Series A, Jan 20, 2011, $2.5M — Tech Coast Angels, Golden Seeds, Pittsburgh Life Sciences Greenhouse, M5Invest Partners, TMC Investment, Innovation Works, Ogden CAP, LLC, The Breedlove Limited Family Partnership
- Series A, Jul 15, 2009, $1.2M — Pittsburgh Life Sciences Greenhouse, M5Invest Partners, Innovation Works, Ogden CAP, LLC

## Investors

- Pittsburgh Life Sciences Greenhouse (https://capitalatlas.ai/funds/pittsburgh-life-sciences-greenhouse) — Series A, Series B
- M5Invest Partners — Series A, Series B
- Innovation Works (https://capitalatlas.ai/funds/innovation-works) — Series A
- Ogden CAP, LLC — Series A, Series B
- Tech Coast Angels — Series A, Series B
- Golden Seeds (https://capitalatlas.ai/funds/golden-seeds) — Series A, Series B
- TMC Investment — Series A
- The Breedlove Limited Family Partnership — Series A
- Bios Partners (https://capitalatlas.ai/funds/bios-partners) — Series B
- Maine Angels — Series B
- Cowtown Angels (https://capitalatlas.ai/funds/cowtown-angels) — Series B
- Dolby Family Ventures (https://capitalatlas.ai/funds/dolby-family-ventures) — Series B
- ACE Fund — Series B
- Scale Investors (https://capitalatlas.ai/funds/scale-investors) — Series B
- Ariel Southeast Angel Partners (https://capitalatlas.ai/funds/ariel-southeast-angel-partners) — Series B